DYRK1B is associated with a metabolic syndrome known as abdominal obesity-metabolic syndrome 3 (AOMS3), which is characterized by abdominal obesity, type-2 diabetes, hypertension, and heart diseases (OMIM #615812). Here, DYRK1B is linked to hypertensive disorder.